The DOI matches its Crossref record; 86 of the 86 references it cites were found in a registry or an index.
Mechanisms linking obesity with cardiovascular disease
Abstract
Obesity increases the risk of cardiovascular disease and premature death. Adipose tissue releases a large number of bioactive mediators that influence not only body weight homeostasis but also insulin resistance - the core feature of type 2 diabetes - as well as alterations in lipids, blood pressure, coagulation, fibrinolysis and inflammation, leading to endothelial dysfunction and atherosclerosis. We are now beginning to understand the underlying mechanisms as well as the ways in which smoking and dyslipidaemia increase, and physical activity attenuates, the adverse effects of obesity on cardiovascular health.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Obesity is strongly associated with the development of major risk factors for atherosclerotic disease such as hypertension, hyperlipidemia, and diabetes (79, 89, 358).”
From Cardiac remodeling in obesity (2008) · cites this paper as [358]
In the citing paper
“In addition, endothelial dysfunction is widely present in obesity and the metabolic syndrome (84, 325, 358).”
From Cardiac remodeling in obesity (2008) · cites this paper as [358]
In the citing paper
“In other populations, such as those in the STRONG heart study (native Americans of the western United States) and the Framingham heart study, diabetes or the metabolic syndrome do appear to be significant risk factors for LV hypertrophy (272, 306, 358).”
From Cardiac remodeling in obesity (2008) · cites this paper as [358]
Citations
Cites
1 retracted
Visfatin: A Protein Secreted by Visceral Fat That Mimics the Effects of Insulin
Fukuhara, A., Matsuda, M., Nishizawa, M., Segawa, K., Tanaka, M., Kishimoto, K., Matsuki, Y., Murakami, M., Ichisaka, T., Murakami, H., et al. (2005) · Science · doi:10.1126/science.1097243 · Cited by 1,906
RetractedYusuf, S., Hawken, S., Ôunpuu, S., Dans, T., Avezum, A., Lanas, F., McQueen, M., Budaj, A., Pais, P., Varigos, J., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17018-9 · Cited by 12,026
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041
Inflammation and Atherosclerosis
Libby, P., Ridker, P. M., & Maseri, A. (2002) · Circulation · doi:10.1161/hc0902.104353 · Cited by 7,724
Berenson, G. S., Srinivasan, S. R., Bao, W., Newman, W. P., Tracy, R. E., & Wattigney, W. A. (1998) · New England Journal of Medicine · doi:10.1056/nejm199806043382302 · Cited by 4,032
Poirier, P., Giles, T. D., Bray, G. A., Hong, Y., Stern, J. S., Pi-Sunyer, F. X., & Eckel, R. H. (2006) · Circulation · doi:10.1161/circulationaha.106.171016 · Cited by 3,165
Obesity and the risk of heart failure
Kenchaiah, S., Evans, J. C., Levy, D., Wilson, P. W. F., Benjamin, E. J., Larson, M. G., Kannel, W. B., & Vasan, R. S. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020245 · Cited by 3,093
Yusuf, S., Hawken, S., Ôunpuu, S., Bautista, L., Franzosi, M. G., Commerford, P., Lang, C. C., Rumboldt, Z., Onen, C. L., Lisheng, L., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67663-5 · Cited by 2,903
A Potential Decline in Life Expectancy in the United States in the 21st Century
Olshansky, S. J., Passaro, D. J., Hershow, R. C., Layden, J., Carnes, B. A., Brody, J., Hayflick, L., Butler, R. N., Allison, D. B., & Ludwig, D. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmsr043743 · Cited by 2,612
Overweight, Obesity, and Mortality in a Large Prospective Cohort of Persons 50 to 71 Years Old
Adams, K. F., Schatzkin, A. G., Harris, T. B., Kipnis, V., Mouw, T., Ballard-Barbash, R. R., Hollenbeck, A. R., & Leitzmann, M. F. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055643 · Cited by 2,147
Flagged first, then by citations
Cited by
Sorted by citations
Items 301–400 of 1,009
Maternal high-fat diet alters anxiety behavior and glucocorticoid signaling in adolescent offspring
Sasaki, A., Vega, W. D., Sivanathan, S., St-Cyr, S., & McGowan, P. O. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.04.012 · Cited by 116
“High-fat exposure during development has been linked with adverse health outcomes such as diabetes and coronary heart disease (Marx, 2002; Kahn et al., 2006; Van Gaal et al., 2006; Bersamin et al., 2008).”
Adipocytokine Levels in Obese and Non-obese Subjects: an Observational Study
Derosa, G., Fogari, E., D’Angelo, A., Bianchi, L., Bonaventura, A., Romano, D., & Maffioli, P. (2013) · Inflammation · doi:10.1007/s10753-013-9620-4 · Cited by 119
“Overweight and obesity are increasing health problems associated with cardiovascular disorders and premature mortality [1].”
Immune Mediators in Patients With Acute Diabetic Foot Syndrome
Weigelt, C., Rose, B., Poschen, U., Ziegler, D., Friese, G., Kempf, K., Köenig, W., Martin, S., & Herder, C. (2009) · Diabetes Care · doi:10.2337/dc08-2318 · Cited by 119
Obesity, metabolic syndrome, adipocytes and vascular function: A holistic viewpoint
Achike, F. I., To, N. P., Wang, H., & Kwan, C. (2010) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2010.05460.x · Cited by 116
Hyötyläinen, T., Jerby‐Arnon, L., Petäjä, E. M., Mattila, I. M., Jäntti, S. E., Auvinen, P., Gastaldelli, A., Yki‐Järvinen, H., Ruppin, E., & Orešič, M. (2016) · Nature Communications · doi:10.1038/ncomms9994 · Cited by 114
Du, J., Shen, L., Tan, Z., Zhang, P., Zhao, X., Xu, Y., Gan, M., Yang, Q., Ma, J., Jiang, A., et al. (2018) · Nutrients · doi:10.3390/nu10020131 · Cited by 119
Choi, S., Kim, K., Kim, S. M., Lee, G., Jeong, S., Park, S. Y., Kim, Y.-Y., Yun, J., Yun, J., & Park, S. M. (2018) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2018.2310 · Cited by 115
Fang, L., Guo, F., Zhou, L., Stahl, R. D., & Grams, J. M. (2015) · Adipocyte · doi:10.1080/21623945.2015.1034920 · Cited by 118
“It is associated with an increased risk of type 2 diabetes mellitus, metabolic syndrome, cardiovascular disease, and cancer.(2-6) The mechanism by which obesity promotes dysmetabolism is not fully understood, but the literature implicates adipose tissue itself in the pathophysiology.”
BackgroundFrom NAFLD to MAFLD: Definition, Pathophysiological Basis and Cardiovascular Implications
Boccatonda, A., Andreetto, L., D’Ardes, D., Cocco, G., Rossi, I., Vicari, S., Schiavone, C., Cipollone, F., & Guagnano, M. T. (2023) · Biomedicines · doi:10.3390/biomedicines11030883 · Cited by 116
Early development of the metabolic syndrome after chemotherapy for testicular cancer
de Haas, E. C., Altena, R., Boezen, H. M., Zwart, N. R. K., Smit, A. J., Bakker, S. J. L., van Roon, A. M., Postma, A., Wolffenbuttel, B. H. R., Hoekstra, H. J., et al. (2012) · Annals of Oncology · doi:10.1093/annonc/mds527 · Cited by 113
Hwang, C.-L., Wu, Y.-T., & Chou, C.-H. (2011) · Journal of Cardiopulmonary Rehabilitation and Prevention · doi:10.1097/hcr.0b013e31822f16cb · Cited by 111
Obesity Paradox in Advanced Kidney Disease: From Bedside to the Bench
Naderi, N., Kleine, C., Park, C., Hsiung, J., Soohoo, M., Tantisattamo, E., Streja, E., Kalantar‐Zadeh, K., & Moradi, H. (2018) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2018.07.001 · Cited by 113
“Obesity, as defined by a body mass index (BMI) ≥30 kg/m2 (1), is a growing worldwide epidemic (2), which is associated with serious sequelae including higher risk of cardiovascular disease (CVD) and mortality (3-5).”
BackgroundTreating NASH by targeting peroxisome proliferator-activated receptors
Staels, B., Butruille, L., & Francque, S. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.07.004 · Cited by 114
Aubin, M.-C., Lajoie, C., Clément, R., Gosselin, H., Calderone, A., & Perrault, L. P. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.135061 · Cited by 109
Endothelial Dysfunction in Children Without Hypertension
Bhattacharjee, R., Kim, J., Alotaibi, W., Gozal, D., Capdevila, Ó. S., & Gozal, D. (2011) · CHEST Journal · doi:10.1378/chest.11-1777 · Cited by 112
The usefulness of circulating adipokine levels for the assessment of obesity-related health problems
Inadera, H. (2008) · International Journal of Medical Sciences · doi:10.7150/ijms.5.248 · Cited by 109
Health Risks Associated with High Waist Circumference: A Systematic Review
Darsini, D., Hamidah, H., Notobroto, H. B., & Cahyono, E. A. (2020) · Journal of Public Health Research · doi:10.4081/jphr.2020.1811 · Cited by 108
Lyu, N., Du, Z., Qiu, H., Gao, P., Yao, Q., Xiong, K., Tu, Q., Li, X., Chen, B., Wang, M., et al. (2020) · Advanced Science · doi:10.1002/advs.202002330 · Cited by 107
Yamamoto, E., Dong, Y., Kataoka, K., Yamashita, T., Tokutomi, Y., Matsuba, S., Ichijo, H., Ogawa, H., & Kim‐Mitsuyama, S. (2008) · Hypertension · doi:10.1161/hypertensionaha.108.112292 · Cited by 109
Subclinical Inflammation and Diabetic Polyneuropathy
Herder, C., Lankisch, M., Ziegler, D., Rathmann, W., Köenig, W., Illig, T., Döring, A., Thorand, B., Holle, R., Giani, G., et al. (2009) · Diabetes Care · doi:10.2337/dc08-2011 · Cited by 108
Effect of Long-Term Whole Body Vibration Training on Visceral Adipose Tissue: A Preliminary Report
Vissers, D., Verrijken, A., Mertens, I., Gils, C. V., de Sompel, A. V., Truijen, S., & van Gaal, L. (2010) · Obesity Facts · doi:10.1159/000301785 · Cited by 125
Self-citationKokubo, Y., Okamura, T., Yoshimasa, Y., Miyamoto, Y., Kawanishi, K., Kotani, Y., Okayama, A., & Tomoike, H. (2008) · Hypertension Research · doi:10.1291/hypres.31.2027 · Cited by 107
AMP-Activated Protein Kinase and Metabolic Control
Viollet, B., & Andréelli, F. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-17214-4_13 · Cited by 113
Reward-Induced Eating: Therapeutic Approaches to Addressing Food Cravings
Rebello, C. J., & Greenway, F. L. (2016) · Advances in Therapy · doi:10.1007/s12325-016-0414-6 · Cited by 109
“diet, but adherence to a diet regimen that promotes energy restriction [6].”
BackgroundObesity phenotypes and cardiovascular risk: From pathophysiology to clinical management
Preda, A., Carbone, F., Tirandi, A., Montecucco, F., & Liberale, L. (2023) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-023-09813-5 · Cited by 114
Anti-inflammatory Properties of Orange Juice: Possible Favorable Molecular and Metabolic Effects
Coelho, R. C. L. A., Hermsdorff, H. H. M., & Bressan, J. (2013) · Plant Foods for Human Nutrition · doi:10.1007/s11130-013-0343-3 · Cited by 105
“Several studies demonstrated increased expression of nuclear transcription factors such as nuclear factor kappa-B (NF-κB), interleukin (IL), and tumor necrosis factor alpha (TNFa) in obeses [2, 3].”
O’Donnell, D. E., Ciavaglia, C. E., & Neder, J. A. (2014) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201312-438fr · Cited by 104
Role of ω3 Longchain Polyunsaturated Fatty Acids in Reducing Cardio- Metabolic Risk Factors
Abeywardena, M. Y., & Patten, G. S. (2011) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/187153011796429817 · Cited by 106
Bioelectronic medicine: Preclinical insights and clinical advances
Pavlov, V. A., & Tracey, K. J. (2022) · Neuron · doi:10.1016/j.neuron.2022.09.003 · Cited by 110
Xia, X., Chen, S., Tian, X., Xu, Q., Zhang, Y., Zhang, X., Li, J., Wu, S., & Wang, A. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02290-3 · Cited by 104
“Fat mass and central obesity also play an important role in the progress of atherogenic endothelial dysfunction partly through metabolic disorders, which ultimately lead to the occurrence of ASCVD [11, 12].”
BackgroundArteriolar Function in Visceral Adipose Tissue Is Impaired in Human Obesity
Farb, M. G., Ganley-Leal, L. M., Mott, M. M., Liang, Y., Ercan, B., Widlansky, M. E., Bigornia, S., Fiscale, A. J., Apovian, C. M., Carmine, B. J., et al. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.235846 · Cited by 102
Kishi, S., Armstrong, A. D. C., Gidding, S. S., Colangelo, L. A., Ambale‐Venkatesh, B., Jacobs, D. R., Carr, J. J., Terry, J. G., Liu, K., Goff, D. C., et al. (2014) · JACC Heart Failure · doi:10.1016/j.jchf.2014.03.001 · Cited by 103
Molecular mechanisms of signal transduction via adiponectin and adiponectin receptors
Heiker, J. T., Kosel, D., & Beck‐Sickinger, A. G. (2010) · Biological Chemistry · doi:10.1515/bc.2010.104 · Cited by 105
Obesity, metabolic health, and the risk of end-stage renal disease
Panwar, B., Hanks, L. J., Tanner, R., Muntner, P., Kramer, H., Mcclellan, W., Warnock, D., Judd, S., & Gutiérrez, O. M. (2014) · Kidney International · doi:10.1038/ki.2014.384 · Cited by 103
Multi-Functional Roles of Chitosan as a Potential Protective Agent against Obesity
Walsh, A. M., Sweeney, T., Bahar, B., & O’Doherty, J. V. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053828 · Cited by 104
“Obesity is associated with both increased local adipose and more generalized systemic inflammation [38,39].”
BackgroundPatel, V. B., Basu, R., & Oudit, G. Y. (2016) · Adipocyte · doi:10.1080/21623945.2015.1131881 · Cited by 104
Obesity and cardiovascular outcomes: a review
Ghoorah, K., Campbell, P. T., Kent, A., Maznyczka, A., & Kunadian, V. (2014) · European Heart Journal Acute Cardiovascular Care · doi:10.1177/2048872614523349 · Cited by 101
Chakrabarti, S. K., Wen, Y., Dobrian, A. D., Cole, B. K., Ma, Q., Pei, H., Williams, M. D., Bevard, M. H., Vandenhoff, G. E., Keller, S. R., et al. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00203.2010 · Cited by 103
Virtue, A. T., Johnson, C., Lopez‐Pastrana, J., Shao, Y., Fu, H., Li, X., Li, Y., Yin, Y., Mai, J., Rizzo, V., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.739839 · Cited by 101
“In other words, these patients do not have MetS.”
BackgroundInfluentialTian, X., Chen, S., Wang, P., Xu, Q., Zhang, Y., Luo, Y., Wu, S., & Wang, A. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01729-9 · Cited by 101
“Overweight and obesity (general and central obesity) have harmful effects on CVD risk, and the underlying mechanism has been thoroughly investigated [40].”
BackgroundEstrogen Plus Progestin and Breast Cancer Detection by Means of Mammography and Breast Biopsy
Chlebowski, R. T. (2008) · Archives of Internal Medicine · doi:10.1001/archinternmed.2007.123 · Cited by 101
He, F., Bixler, E. O., Liao, J., Berg, A. S., Kawasawa, Y. I., Fernández‐Mendoza, J., Vgontzas, A. N., & Liao, D. (2015) · Sleep Medicine · doi:10.1016/j.sleep.2015.07.028 · Cited by 101
“Previous literature has also demonstrated associations between childhood obesity and increased risk of metabolic alterations and disease, such as insulin resistance, dyslipidemia, and metabolic syndrome [3,4].”
BackgroundCognitive Changes and Brain Volume Reduction in Patients with Nonalcoholic Fatty Liver Disease
Filipović, B. F., Marković, O., Đurić, V., & Filipović, B. (2018) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2018/9638797 · Cited by 100
Chen, Z., Iona, A., Parish, S., Chen, Y., Yu, C., Bragg, F., Yang, L., Bian, Z., Holmes, M. V., Lewington, S., et al. (2018) · The Lancet Global Health · doi:10.1016/s2214-109x(18)30216-x · Cited by 100
Human olfactory dysfunction: causes and consequences
Schäfer, L., Schriever, V. A., & Croy, I. (2021) · Cell and Tissue Research · doi:10.1007/s00441-020-03381-9 · Cited by 100
Ruan, X., Li, Z., Zhang, Y., Yang, L., Pan, Y., Wang, Z., Feng, G., & Chen, Y. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01045.x · Cited by 97
Sandforth, A., von Schwartzenberg, R. J., Arreola, E. V., Hanson, R. L., Sancar, G., Katzenstein, S., Lange, K., Preißl, H., Dreher, S. I., Weigert, C., et al. (2023) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(23)00235-8 · Cited by 100
Peralta, F. G., Abreu, C., Cruz-Bravo, M., Alcarria, E., Gutiérrez-Buey, G., Krakauer, N. Y., & Krakauer, J. C. (2018) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-018-0323-8 · Cited by 98
“Of note, the DECODE study group found a positive linear relationship of all-cause CVD mortality with ABSI, whereas BMI, WC, and WHR showed J-shaped associations [17].”
BackgroundThe Prevalence of Metabolically Healthy and Unhealthy Obesity according to Different Criteria
Liu, C., Wang, C., Guan, S., Liu, H., Wu, X., Zhang, Z., Gu, X., Zhang, Y., Zhao, Y., Tse, L. A., et al. (2019) · Obesity Facts · doi:10.1159/000495852 · Cited by 99
Effects of Temperature and Relative Humidity on DNA Methylation
Bind, M., Zanobetti, A., Gasparrini, A., Peters, A., Coull, B. A., Baccarelli, A., Tarantini, L., Koutrakis, P., Vokonas, P., & Schwartz, J. D. (2014) · Epidemiology · doi:10.1097/ede.0000000000000120 · Cited by 103
Maternal high-fat diet impacts endothelial function in nonhuman primate offspring
Fan, L., Lindsley, S. R., Comstock, S. M., Takahashi, D. L., Evans, A. E., He, G.-W., Thornburg, K. L., & Grove, K. L. (2013) · International Journal of Obesity · doi:10.1038/ijo.2012.42 · Cited by 98
Is Primary Aldosteronism Associated with Diabetes Mellitus? Results of the German Conn's Registry
Reincke, M., Meisinger, C., Holle, R., Quinkler, M. O., Hahner, S., Beuschlein, F., Bidlingmaier, M., Seißler, J., & Endres, S. (2010) · Hormone and Metabolic Research · doi:10.1055/s-0029-1246189 · Cited by 98
Wallner, M., Marculescu, R., Doberer, D., Wolzt, M., Wagner, O. F., Vı́tek, L., Bulmer, A. C., & Wagner, K. (2013) · Clinical Science · doi:10.1042/cs20120661 · Cited by 98
A prospective study of weight change and systemic inflammation over 9 y
Fogarty, A., Glancy, C., Jones, S. G., Lewis, S., McKeever, T. M., & Britton, J. R. (2008) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.1.30 · Cited by 98
Obesity and the gut microbiome: Striving for causality
Harley, I. T. W., & Karp, C. L. (2012) · Molecular Metabolism · doi:10.1016/j.molmet.2012.07.002 · Cited by 99
“Obesity is a major risk factor for common, serious medical conditions, including type 2 diabetes, atherosclerotic cardiovascular disease, nonalcoholic fatty liver disease, Alzheimer’s disease and diverse cancers [2,13,34,98,106,126].”
BackgroundNASH and atherosclerosis are two aspects of a shared disease: Central role for macrophages
Bieghs, V., Rensen, P. C. N., Hofker, M. H., & Shiri‐Sverdlov, R. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.08.041 · Cited by 96
CREBH Regulates Systemic Glucose and Lipid Metabolism
Nakagawa, Y., & Shimano, H. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19051396 · Cited by 98
Metabolic and transcriptional response to a high-fat diet in Drosophila melanogaster
Heinrichsen, E. T., Zhang, H., Robinson, J. E., Ngo, J. T., Diop, S. B., Bodmer, R., Joiner, W. J., Metallo, C. M., & Haddad, G. G. (2013) · Molecular Metabolism · doi:10.1016/j.molmet.2013.10.003 · Cited by 97
“These phenotypic changes resemble those seen in human obesity [6,7,22,23], strengthening the use of Drosophila as a model system for studying obesity.”
ResultPisto, P., Santaniemi, M., Bloigu, R., Ukkola, O. H., & Kesäniemi, Y. A. (2014) · BMJ Open · doi:10.1136/bmjopen-2014-004973 · Cited by 100
Parim, B., Nemani, H., Meriga, B., Mehar, S. K., Potana, S., & Ramgopalrao, S. (2014) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2014.07.008 · Cited by 101
Association of SIRT1 gene variation with visceral obesity
Peeters, A. V., Beckers, S., Verrijken, A., Mertens, I. L., Roevens, P. W. M., Peeters, P. J., Hul, W. V., & Gaal, L. F. V. (2008) · Human Genetics · doi:10.1007/s00439-008-0567-8 · Cited by 98
Self-citationMonroy, A., Kamath, S., Chávez, A. O., Centonze, V. E., Veerasamy, M., Barrentine, A., Wewer, J. J., Coletta, D. K., Jenkinson, C. P., Jhingan, R. M., et al. (2009) · Diabetologia · doi:10.1007/s00125-009-1451-3 · Cited by 98
Duration of obesity and overweight and risk of type 2 diabetes among US women
Hu, Y., Bhupathiraju, S. N., de Koning, L., & Hu, F. B. (2014) · Obesity · doi:10.1002/oby.20851 · Cited by 104
“T2D, cardiovascular diseases and all-cause mortality (3-7).”
Pharmacological treatment and therapeutic perspectives of metabolic syndrome
Lim, S. K., & Eckel, R. H. (2014) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-014-9298-4 · Cited by 98
“tissue induces systemic inflammation due to an increase of secretory factors derived from adipocytes and macrophages embedded in this tissue [21].”
BackgroundImpact of Health Labels on Flavor Perception and Emotional Profiling: A Consumer Study on Cheese
Schouteten, J. J., Steur, H. D., Pelsmaeker, S. D., Lagast, S., Bourdeaudhuij, I. D., & Gellynck, X. (2015) · Nutrients · doi:10.3390/nu7125533 · Cited by 91
“Its reduction may help lower the energy intake [8] and therefore prevent obesity which could lead to heart disease [9,10].”
BackgroundSong, E., Han, K., Lim, T.-J., Lim, S., Chung, M.-J., Nam, M. H., Kim, H., & Nam, Y. (2020) · The EPMA Journal · doi:10.1007/s13167-020-00198-y · Cited by 101
Krüppel-like family of transcription factors: an emerging new frontier in fat biology
Brey, C. W., Nelder, M. P., Hailemariam, T. K., Gaugler, R. R., & Hashmi, S. (2009) · International Journal of Biological Sciences · doi:10.7150/ijbs.5.622 · Cited by 93
Vest, A. R., Patel, P., Schauer, P. R., Satava, M. E., Cavalcante, J. L., Brethauer, S. A., & Young, J. B. (2016) · Circulation Heart Failure · doi:10.1161/circheartfailure.115.002260 · Cited by 93
“1 The prevalence of obesity has reached epidemic proportions globally and is associated with widespread alterations in cardiovascular structure and function.(1,2) Elevated body mass index (BMI) and other anthropometric measures of obesity are independent risk factors for the development of heart failure (HF), with eit…”
BackgroundZeng, X., Jedrychowski, M. P., Chen, Y., Serag, S., Lavery, G. G., Gygi, S. P., & Spiegelman, B. M. (2016) · Genes & Development · doi:10.1101/gad.285312.116 · Cited by 93
Body Mass Index and the Risk of All-Cause Mortality Among Patients With Type 2 Diabetes Mellitus
Zhao, W., Katzmarzyk, P. T., Horswell, R. L., Wang, Y., Li, W., Johnson, J. L., Heymsfield, S. B., Cefalu, W. T., Ryan, D. H., & Hu, G. (2014) · Circulation · doi:10.1161/circulationaha.114.009098 · Cited by 92
“Obesity is a wellestablished risk factor for numerous chronic diseases,(32) and adipose tissue can release a large number of cytokines and bioactive mediators that play important roles in the pathogenesis of many obesity-related cardiovascular diseases.(33) There are several strengths in our study, including the large…”
BackgroundTesauro, M., Schinzari, F., Rovella, V., Daniele, N. D., Lauro, D., Mores, N., Veneziani, A., & Cardillo, C. (2009) · Hypertension · doi:10.1161/hypertensionaha.109.137729 · Cited by 92
Physical Activity and Leg Strength Predict Decline in Mobility Performance in Older Persons
Buchman, A. S., Wilson, R. S., Boyle, P. A., Tang, Y., Fleischman, D. A., & Bennett, D. A. (2007) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2007.01359.x · Cited by 92
Mechanisms Linking Nonalcoholic Fatty Liver Disease with Coronary Artery Disease
Nseir, W., Shalata, A., Marmor, A. T., & Assy, N. (2011) · Digestive Diseases and Sciences · doi:10.1007/s10620-011-1767-y · Cited by 93
Malarvannan, G., Dirinck, E. L., Dirtu, A. C., Pereira-Fernandes, A., Neels, H. M., Jorens, P. G., Gaal, L. V., Blust, R., & Covaci, A. (2013) · Environment International · doi:10.1016/j.envint.2013.02.012 · Cited by 90
Retinol-binding protein 4 in obesity and metabolic dysfunctions
Nankam, P. A. N., & Blüher, M. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111312 · Cited by 93
Landscape of cardiometabolic risk factors in Chinese population: a narrative review
Li, J., Liu, H., & Li, S. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01551-3 · Cited by 92
Mendes, M. S. F., Cousin, E., Malta, D. C., Machado, I. E., Ribeiro, A. L. P., Duncan, B. B., Schmidt, M. A. M. D. S., da Silva, D. D. C. S. A., Glenn, S., Afshin, A., et al. (2020) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · doi:10.1186/s12963-020-00219-y#:~:text=overall%2c%20burden%20due%20to%20high,6.0%25)%20in%201990%2c%20respectively · Cited by 91
Health and mortality consequences of abdominal obesity: evidence from the AusDiab study
Cameron, A. J., Dunstan, D. W., Owen, N. G., Zimmet, P., Barr, E., Tonkin, A. M., Magliano, D. J., Murray, S. G., Welborn, T. A., & Shaw, J. E. (2009) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2009.tb02753.x · Cited by 88
Zoicas, F., & Schöfl, C. (2012) · Frontiers in Endocrinology · doi:10.3389/fendo.2012.00046 · Cited by 91
“Together, these metabolic alterations increase the risk of hypertension, diabetes, and atherosclerosis, which all lead to cardiovascular disease and mortality from vascular events (Van Gaal et al., 2006).”
BackgroundBaskin, K. K., Grueter, C. E., Kusminski, C. M., Holland, W. L., Bookout, A. L., Satapati, S., Kong, Y. M., Burgess, S. C., Malloy, C. R., Scherer, P. E., et al. (2014) · EMBO Molecular Medicine · doi:10.15252/emmm.201404218 · Cited by 92
“Obesity has reached epidemic proportions worldwide and is associated with increased risk of cardiovascular disease, hypertension, and diabetes, resulting in enhanced morbidity and mortality (Van Gaal et al, 2006).”
Oxidation, glycation and glycoxidation—The vicious cycle and lung cancer
Ahmad, S., Khan, M. Y., Rafi, Z., Khan, H., Siddiqui, Z., Rehman, S., Shahab, U., Khan, M. S., Saeed, M., Alouffi, S., et al. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.10.005 · Cited by 91
Roth, C. L. (2015) · Journal of Clinical Medicine · doi:10.3390/jcm4091774 · Cited by 90
“Thus, early and effective management of obesity is vital for these patients [48], which are more”
BackgroundCavaliere, G., Cimmino, F., Trinchese, G., Catapano, A., Petrella, L., D’Angelo, M., Lucchin, L., & Mollica, M. P. (2023) · Antioxidants · doi:10.3390/antiox12061172 · Cited by 104
Hermsdorff, H. H. M., Zulet, M. Á., Abete, I., & Martínez, J. A. (2009) · Endocrine · doi:10.1007/s12020-009-9248-1 · Cited by 90
da Silveira, J. A. C., Taddei, J. A. D. A. C., Guerra, P. H., & Nobre, M. R. C. (2013) · Preventive Medicine · doi:10.1016/j.ypmed.2013.01.011 · Cited by 92
Cardiovascular Risk-Benefit Profile of Sibutramine
Scheen, A. J. (2010) · American Journal of Cardiovascular Drugs · doi:10.2165/11584800-000000000-00000 · Cited by 89
Ali, S. E., Farag, M. A., Holvoet, P., Hanafi, R. S., & Gad, M. Z. (2016) · Scientific Reports · doi:10.1038/srep36359 · Cited by 89
Impact of Discrepancies in General and Abdominal Obesity on Major Adverse Cardiac Events
Choi, D., Choi, S., Son, J. S., Oh, S. W., & Park, S. M. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.119.013471 · Cited by 91
A systematic review on different models of inducing obesity in animals: Advantages and limitations
Suleiman, J. B., Mohamed, M., & Bakar, A. B. A. (2020) · Journal of Advanced Veterinary and Animal Research · doi:10.5455/javar.2020.g399 · Cited by 100
“This, in turn, leads to coronary heart disease [23].”
BackgroundOf rodents and men: Species-specific glucose regulation and type 2 diabetes research
Chandrasekera, P. C. (2014) · ALTEX · doi:10.14573/1309231 · Cited by 88
Black soybean anthocyanins inhibit adipocyte differentiation in 3T3-L1 cells
Kim, H., Kim, J. N., Han, S. N., Nam, J., Na, H.-N., & Ha, T. J. (2012) · Nutrition Research · doi:10.1016/j.nutres.2012.06.008 · Cited by 89
“evident in enlarged mature fat cells, and an elevated level of circulating FFAs has been suggested to function as a mediator of insulin resistance [29] and cardiovascular disease associated with obesity [30,31].”
BackgroundNanotoxicity: A Growing Need for Study in the Endocrine System
Lu, X., Liu, Y., Kong, X., Lobie, P. E., Chen, C., & Zhu, T. (2013) · Small · doi:10.1002/smll.201201517 · Cited by 89
Bellisario, V., Panetta, P., Balsevich, G., Baumann, V., Noble, J., Raggi, C., Nathan, O., Berry, A., Seckl, J., Schmidt, M., et al. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.06.012 · Cited by 88
Qi, D., Tang, X., He, J., Wang, D., Zhao, Y., Deng, W., Deng, X., Zhou, G., Xia, J., Zhong, X. Z., et al. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.265 · Cited by 88
Carrera-Lanestosa, A., Moguel-Ordóñez, Y., & Campos, M. R. S. (2017) · Journal of Medicinal Food · doi:10.1089/jmf.2016.0171 · Cited by 88
Shedding new light on lipid functions with CARS and SRS microscopy
Yu, Y., Ramachandran, P. V., & Wang, M. C. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.02.003 · Cited by 89
Reliability of leptin, but not adiponectin, as a biomarker for diet-induced weight loss in humans
Klempel, M. C., & Varady, K. A. (2011) · Nutrition Reviews · doi:10.1111/j.1753-4887.2011.00373.x · Cited by 86
Neamat‐Allah, J., Wald, D., Hüsing, A., Teucher, B., Wendt, A. T., Delorme, S., Dinkel, J., Vigl, M., Bergmann, M. M., Feller, S., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091586 · Cited by 86
“Excess body fat is known to be one of the main risk factors for diabetes, as well as cardiovascular diseases [1,2] and several frequent types of cancer [3,4].”
BackgroundTettero, O. M., Aronson, T., Wolf, R. J., Nuijten, M. A. H., Hopman, M. T. E., & Janssen, I. M. C. (2018) · Obesity Surgery · doi:10.1007/s11695-018-3439-x · Cited by 93
Multifactorial Basis and Therapeutic Strategies in Metabolism-Related Diseases
Guerra, J. V. D. S., Dias, M. M. G., Brilhante, A. J. V. C., Terra, M. F., García‐Arévalo, M., & Figueira, A. C. M. (2021) · Nutrients · doi:10.3390/nu13082830 · Cited by 92
“The dyslipidemia process can induce CVDs, such as hypertension, myocardial infarction, and stroke [57,58].”
Background
Metadata
- Authors
- Van Gaal, L. F., Mertens, I. L., & De Block, C. E.
- Affiliations
- University of Antwerp (BE)
- Venue
- Nature
- Published
- 2006-12
- Volume
- 444
- Issue
- 7121
- Pages
- 875-880
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1964607854
- Cited by
- 2,814
- References
- 86
- Citations by year
- 2026: 64 · 2025: 97 · 2024: 126 · 2023: 137 · 2022: 151 · 2021: 172 · 2020: 179 · 2019: 204 · 2018: 172 · 2017: 173 · 2016: 168 · 2015: 193 · 2014: 194 · 2013: 152 · 2012: 128
- FWCI
- 11.30
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- obesity, cardiovascular disease, adipose tissue, adipokines, insulin resistance, type 2 diabetes, dyslipidemia, blood pressure, coagulation, fibrinolysis, inflammation, endothelial dysfunction, atherosclerosis, smoking, physical activity, premature mortality
- MeSH terms
- Cardiovascular Diseases, Endothelium, Vascular, Humans, Insulin Resistance, Obesity, Oxidative Stress, Adiposity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review